Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Exercise | $2.2K | SEC | |
| ExerciseD | $0 | SEC | |
| Buy | $33.9K | SEC | |
| AwardD | $0 | SEC | |
| Other | $272.8K | SEC | |
| Buy | $60.9K | SEC | |
| AwardD | $0 | SEC | |
| Award | — | SEC | |
| Buy | $27.3K | SEC | |
| Buy | $8.4K | SEC | |
| AwardD | $0 | SEC | |
| AwardD | $0 | SEC | |
| Other | $0 | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $4.1K | SEC | |
| AwardD | $0 | SEC | |
| AwardD | $0 | SEC | |
| Buy | $17.8K | SEC | |
| Buy | $4.2K | SEC | |
| Buy | $1.4K | SEC | |
| Buy | $1.5K | SEC | |
| Buy | $5.4K | SEC | |
| Buy | $1.3K | SEC | |
| Buy | $4.2K | SEC | |
| Buy | $798.9 | SEC |